SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is trending amidst intense market volatility driven by escalating geopolitical tensions surrounding discussions of tariffs linked to Greenland. Community sentiment is sharply divided, with some investors anticipating a significant market downturn due to uncertainty and potential European retaliation, while others expect a swift "buy the dip" rebound, referencing past instances where tariff-related drops quickly reversed.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending due to heightened geopolitical tensions stemming from discussions between the U.S. and European nations regarding potential tariffs and Greenland. This situation has driven a risk-off sentiment across the crypto market, sparking community debates about Bitcoin's role as a safe haven asset, even as some investors see current price movements as a chance to accumulate.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending significantly as renewed geopolitical tensions intensify, primarily driven by discussions around potential US tariffs on European countries concerning Greenland. This has sparked community debate regarding gold's role as a safe-haven asset, with many anticipating further upside amid broader uncertainty and concerns over currency debasement, while others caution about an overextended rally. The ongoing criticism of the Federal Reserve's independence adds another layer of market uncertainty supporting precious metals.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

United States Natural Gas Fund ($UNG) is trending as an intensifying Arctic air invasion across large parts of the US is forecast to drive a significant surge in heating demand. The community is buzzing about a potential short squeeze, given extreme short interest and the sudden shift to frigid weather, though acknowledging the commodity's notorious volatility. This immediate weather catalyst is compounded by emerging long-term demand narratives surrounding AI data centers.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending due to strong anticipation ahead of its upcoming earnings report, coupled with widespread speculation about major government foundry contracts and a potential significant client win for its advanced chip manufacturing. The community is actively discussing Intel's potential comeback and its perceived undervaluation compared to industry peers, driven by the broader narrative of domestic semiconductor manufacturing and surging demand for AI and server chips.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as renewed tariff threats and geopolitical statements from former President Trump regarding European allies and Greenland ignite market concern. While many anticipate a market dip, a strong 'buy the dip' sentiment persists among some traders, recalling past swift recoveries in the tech-heavy index.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending following recent international approvals for its cancer immunotherapies, notably in Saudi Arabia for lung cancer, alongside updated positive clinical study results. The community is enthusiastically discussing the potential of Anktiva to revolutionize cancer treatment and is vocal about perceived US FDA delays, which is fueling significant speculation around a short squeeze. Investors are expressing strong optimism regarding Dr. Soon-Shiong's strategic vision and the company's considerable growth trajectory.

Memecoin on Injective taken over by the community.

Nonja

NONJA CRYPTO is trending as a high-conviction meme on the Injective blockchain, currently energized by a governance proposal aiming to significantly boost $INJ's deflation rate and strong institutional interest. The community widely views $NONJA as a resilient and "unruggable" asset, boasting burned liquidity and an active base, making it the go-to leveraged play for Injective's anticipated growth during the next market cycle. Many believe $NONJA is well-positioned for outsized returns as the underlying chain continues to mature and gain recognition.

VanEck ETF Trust - VanEck Junior Gold Miners ETF

VanEck Junior Gold Miners ETF

The VanEck Junior Gold Miners ETF ($GDXJ) is trending as gold and silver prices surge, with the community largely viewing junior miners as a leveraged play on this rally. Many anticipate significant upside and undervaluation in the sector, driven by global economic uncertainties and expectations of continued demand for precious metals.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending due to significant uncertainty surrounding the Digital Asset Market Clarity Act, after its CEO withdrew support over concerns about stablecoin rewards and other provisions, leading to the Senate postponing a key hearing. Community discussion reflects frustration with the stock's underperformance despite broader crypto movements, with many debating if the CEO's stance is a strategic long-term win or a short-term blow for vital revenue streams.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Tilray’s Q2 revenue rose 3% to $217.5 million, beating estimates of $211.5 million, according to Fiscal.ai data</li><li>The management reaffirmed its fiscal 2026 adjusted EBITDA outlook of $62 million to $72 million.</li><li>Tilray is currently operating at an annualized run rate of about $150 million, CEO Irwin D. Simon told analysts on a call on Thursday.</li></ul>Tilray Brands (TLRY) stock gave up most of its early gains to trade about 2.5% higher on Friday after Alliance Global slashed its price target on the stock, pointing to limited visibility into the company’s long-term sales trajectory and cash flow following its second-quarter (Q2) fiscal 2026 results.Analyst Aaron Grey reduced Tilray’s target price to $10 from $20 while maintaining a ‘Neutral’ rating. He said the quarter came in largely in line at the consolidated level, with “some strengths offsetting some weaknesses,” but the firm stayed on the sidelines, looking for clearer insight into the company’s sales and cash flow outlook.<h2 class="st-heading-2">Q2 Print</h2>Tilray’s second-quarter (Q2) revenue rose 3% to $217.5 million, beating estimates of $211.5 million, according to Fiscal.ai data. The revenue increase was driven by a 36% jump in international medical cannabis sales. Net loss narrowed to $43.5 million from $85.3 million a year earlier.Operating cash flow remained negative, though it narrowed to $8.5 million compared to $40.7 million last year. The firm’s management reaffirmed its fiscal 2026 adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) outlook of $62 million to $72 million, citing long-term opportunities tied to U.S. cannabis rescheduling and medical expansion.Chairman and CEO Irwin D. Simon told analysts on a call on Thursday that Tilray is currently operating at an annualized run rate of about $150 million, driven mainly by international markets. Simon also added that Europe, particularly Germany, the U.K., and Poland, represents a significant growth opportunity.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the intraday gains, retail sentiment on Stocktwits for <a href="https://stocktwits.com/symbol/TLRY">TLRY</a> remained in the ‘bearish’ territory over the past 24 hours.<figure class="image"><img src="https://news.stocktwits-cdn.com/TLRY_jpg_463814541d.webp" alt="TLRY.jpg" width="922" height="96"><figcaption>&nbsp;</figcaption></figure>However, some users were bullish, with one highlighting Tilray’s strong results.<stembedurl>https://stocktwits.com/Mlitton13/message/641317326</stembedurl>The stock has declined 24% over the past year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-oklo-stock-surged-premarket-today-meta-deal/cmU2fX3R4dI">OKLO Stock Surged 20% In Premarket Today – What’s The Meta Agreement About?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Tilray Brands logo is seen displayed on a smartphone and in the background.

TLRY Stock In Focus After Alliance Global Halves Price Target

Alliance Global cut TLRY’s target price to $10 from $20, citing limited visibility into the company’s long-term sales trajectory and cash flow.

Equity

Cannabis ETFs Soar Double-Digits on Friday: Here's Why

Cannabis ETFs explode on reform buzz. CNBS, WEED, MSOS and MJ jumped double-digits on Dec. 12, 2025 as Trump reportedly weighs reclassifying marijuana, boosting optimism.

The Zacks Analyst Blog Highlights MSOS, CNBS, WEED, MJ and YOLO

Zacks Analyst Blog highlights MSOS, CNBS, WEED, MJ, and YOLO as marijuana ETFs soar over 100% in three months on U.S. legalization hopes and investor optimism.

From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects 

Marijuana ETFs, such as WEED, MSOS, and CNBS, are rebounding as hopes for rescheduling boost investor optimism. 

Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification

Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.


Nasdaq-listed shares of Canopy Growth Corp. (CGC) fell 12% in pre-market trading on Friday after the cannabis company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.canopygrowth.com/investors/news-releases/canopy-growth-reports-fourth-quarter-and-fiscal-year-2025-financial-results/">reported</a> wider-than-expected fourth-quarter (Q4) loss.The company’s fourth quarter revenue fell 11% year-on-year (YoY) to C$65.03 million ($47.16 million), below an analyst estimate of C$70.87 million, according to Finchat data.The company attributed the drop to a decline in net revenue from its international markets cannabis, and Storz &amp; Bickel segments.In Canada, cannabis net revenue was C$40 million in the quarter, marking an increase of 4% YoY. However, across international markets, the revenue declined 35% YoY to C$8 million, owing to a decline in medical cannabis sales in Poland and Australia, the company said.Storz and Bickel, meanwhile, delivered net revenue of C$17 million in the quarter, a decrease of 23% YoY, owing to softer consumer demand for its devices. Storz and Bickel designs vaporizers for combustion-free vaporization and inhalation of dry herbs.The company’s gross margin fell by 500 basis points to 16% in the quarter, and it reported an adjusted loss before interest, taxes, depreciation, and amortisation (EBITDA) of C$9 million. Analysts had only expected a loss of C$3.13 million.The company’s total debt, however, decreased to C$304 million as of March 31, compared to C$597 million on the corresponding date of 2024.The company said on Friday that it plans to continue to focus on accelerating growth in global medical cannabis, improving commercial execution, and profitability in Canada’s adult-use cannabis market. The company also said that cost actions are underway and it expects annualized savings of at least C$20 million over the next 12 to 18 months.CFO Judy Hong also said that the company is committed to achieving positive adjusted EBITDA in the “near-term,” without specifying a timeline.On Stocktwits, retail sentiment around Canopy Growth stayed within the ‘bearish’ territory over the past 24 hours while message volume rose from ‘normal’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:627/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_30_at_8_59_37_AM_png_cf8cb9e0cf.webp" alt="CGC's Sentiment Meter and Message Volume as of 8:15 a.m. ET on May 30, 2025 | Source: Stocktwits" width="627" height="64"><figcaption>CGC's Sentiment Meter and Message Volume as of 8:15 a.m. ET on May 30, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user termed the Q4 earnings reports “a pretty big let down.” &nbsp;<stembedurl>https://stocktwits.com/JustAGlitchBTMFD/message/616291899</stembedurl><a href="https://stocktwits.com/symbol/CGC">CGC stock </a>is down by about 41% this year and by about 80% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/zymeworks-drug-gets-conditional-approval-for-biliary-tract-cancer-in-china/ch0Mun4RbMx">Zymeworks’ Drug Gets Conditional Approval For Biliary Tract Cancer Treatment In China: Retail Sentiment Refuses To Budge</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.(Exchange Rate: I Canadian Dollar= 0.73 US Dollar)

A cart full of bagged marijuana is rolled through the corridors at the Canopy Growth Corporation headquarters in Smiths Falls, Ontario, on May 15, 2019. (Photo by Lane Turner/The Boston Globe via Getty Images)

Canopy Growth Stock Drops Pre-Market After Disappointing Q4 Earnings: Retail Terms It ‘A Pretty Big Let Down’

CFO Judy Hong said the company is committed to achieving positive adjusted EBITDA in the “near-term,” without specifying a timeline.

Smiths Falls, Ontario-hased&nbsp;Canopy Growth Corp. ($CGC), which has under-delivered relative to expectations in the past few quarters, is scheduled to report its fiscal year 2025 second quarter-results before the market opens on Friday.&nbsp;Analysts, on average, expect the cannabis company to report a quarterly loss of $0.36 per share, narrower than the year-ago loss of $1.15 per share. The consensus revenue estimate is at $46.8 million, down from $53.51 million reported for the second quarter of last fiscal.&nbsp;In the first quarter that ended on June 30, 2024, the company reported revenue of $66.2 million, with roughly 57% coming from the Canadian market. About 15% came from international operations and the remainder from the vaporizer brand Storz &amp; Bickel. The Canadian operation drew equal share of revenue from adult-use cannabis and medical cannabis.Following the second-quarter earnings release, CEO David Klein, who is set to retire by the March quarter, and CFO Judy Hong will host an audio webcast at 10 am ET.In mid-October, the company said it made early prepayment of $100 million worth of senior secured term loan at a discounted price of $97.5 million. This will result in annualized interest expense savings of $14 million, it added.Canopy Growth’s U.S. unit completed the acquisition of Wana during the quarter. With the Wana buy and the purchase of a 75% stake in Jetty, a California-based producer of cannabis extracts and clean vape, the company is looking to solidify its U.S. business.It remains unclear how the incoming Trump administration will regulate the cannabis industry in the U.S. As recently as this week, Florida voted against legalizing recreational marijuana by adults, as the amendment for the same did not achieve the 60% supermajority threshold to pass.&nbsp;During his campaign, Trump said he would support reclassifying marijuana as a Schedule 3 drug, thereby easing federal restrictions on pot.In premarket trading, as of 4:33 am ET, Canopy Growth stock was up 1.10% at $4.60.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/paramount-to-report-q3-results-as-sky-dance-merger-looms-retail-shrugs-off-stock-woes/cJ4EyfkRam">Paramount To Report Q3 Results As SkyDance Merger Looms, Retail Shrugs Off Stock Woes</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

Canopy Growth is looking to turn things around following bottom-line misses in recent quarters.

Canopy Growth Stock Rises Ahead Of Q2 Report As Pot Producers Await  Clarity On Trump’s Policy

Canopy Growth is looking to solidify its U.S. business, thanks to its two acquisitions in the country this year.

Cannabis firm Canopy Growth Corporation was among the top trending stocks on Stocktwits on Friday after the company failed to meet first-quarter earnings estimates.The company reported an earnings loss of C$1.63 compared to an estimated loss of C$0.46 while revenue came in 13% lower on a year-over-year (YoY) basis at C$66.21 million versus an estimate of C$70.1 million.The firm’s net loss widened to C$127.14 million during the quarter compared to a net loss of C$38.12 million in the same quarter a year ago.On the positive side, the company said it has entered into an amendment to its credit agreement with all of the lenders to its senior secured term loan. According to the new agreement, the firm will see significant deleveraging of up to US$200 million.Following the announcement, retail sentiment continued to trend in the ‘bullish territory’ (61/100) although the score inched-down a bit compared to Thursday.<figure class="image"><a href="https://stocktwits.com/symbol/CGC"><img style="aspect-ratio:1888/530;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_08_09_at_9_33_52_AM_c532f1dba8.png" alt="Canopy Growth sentiment meter as of 9:09 a.m. EST on August 09, 2024" width="1888" height="530"></a><figcaption>Canopy Growth sentiment meter as of 9:09 a.m. EST on August 09, 2024</figcaption></figure>Judy Hong, Chief Financial Officer of Canopy Growth Corporation said the firm’s strategic initiatives have led to notable improvements in gross margins and adjusted operating profit as well as reduction in selling, general and administrative (SG&amp;A) expenses. “We are pleased that all of our business units delivered positive Adjusted EBITDA during Q1 Fiscal 2025 and expect to achieve positive Adjusted EBITDA on a consolidated basis in the second half of the fiscal year,” Hong said.On a segmental basis, Canada cannabis net revenue came in at C$38MM in Q1FY2025, registering a decrease of 6% YoY. At the same time, international markets cannabis net revenue declined 1%.The firm also posted a deal update with Canopy USA closing the acquisitions of approximately 75% of the shares of Lemurian, Inc. and two of three Wana entities — Wana Wellness, LLC and The CIMA Group.Stocktwits users are expressing optimism after the earnings announcement and are bullish on the firm’s prospects following the balance sheet restructuring.<stembedurl>https://stocktwits.com/KLONDIKER/message/582426681</stembedurl>Additionally, comments from Republican presidential nominee Donald Trump on Monday suggested a looser policy stance toward Cannabis could be coming, which helped buoy sentiment toward the overall sector.

reported an earnings loss of C$1.63 compared to an estimated loss of C$0.46

Why This Cannabis Firm Is Among The Top Trending On Stocktwits Today

The firm’s net loss widened to C$127.14 million during the quarter compared to a net loss of C$38.12 million in the same quarter a year ago.

The firm’s net loss widened to C$127.14 million during the quarter compared to a net loss of C$38.12 million in the same quarter a year ago. On the positive side, however, the company said it has entered into an amendment to its credit agreement with all of the lenders to its senior secured term loan

Stocktwits sentiment suggests investors are optimistic about McDonald’s prospects, but lack confidence in Tilray Brands and Beyond Inc.’s ability to deliver strong earnings results on Monday.1. Tilray Brands Inc: According to a Street estimate, the cannabis-lifestyle and consumer packaged goods is expected to announce earnings per share (EPS) of (-$0.01) and revenue of $226.94 million when it reports pre-market on Monday. Retail investors have turned cautious on the stock ahead of the announcement with the sentiment meter dipping into neutral territory (54/100) from the bullish zone a day earlier.<figure class="image"><a href="https://stocktwits.com/symbol/TLRY"><img style="aspect-ratio:1578/450;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_26_at_10_18_09_AM_9ef7e56d7b.png" alt="Retail sentiment trends in neutral territory for Tilray Brands ahead of earnings" width="1578" height="450"></a><figcaption>Retail sentiment trends in the neutral territory for Tilray Brands ahead of earnings</figcaption></figure>Recently, the firm’s Germany cannabis cultivation facility, Aphria RX GmbH received the first new cannabis cultivation license issued under MedCanG, Germany’s new Cannabis Act. This allows Aphria RX to cultivate and manufacture a broad commercial range of medical cannabis.&nbsp;However, retail investors remain concerned about the uncertainty around cannabis policies in the backdrop of US elections. Both Kamala Harris and Donald Trump are reportedly known to have displayed mixed stances on cannabis, leading to investor concern about what could materialize once the elections are over.2. Beyond Inc: The online retailer, which owns Overstock, Bed Bath &amp; Beyond, and Zulily, is expected to report second quarter EPS at (-$0.83) and revenue at $382 million after the bell on Monday. Retail investor sentiment recently dipped into bearish territory (42/100) after spending much of the previous month in a bullish zone.Recently, the company said it has reopened Overstock.com, which now has an inventory lineup that includes closeouts, liquidation, factory direct, and reverse logistics merchandise. The management said it is encouraged by accelerating revenue run-rate in the first 90 days.Despite the positive news, retail investors appear to be maintaining caution on the stock as the firm has recently announced structural leadership changes, eliminating the co-Chief Executive roles and the dual chief merchant roles. Investors are trying to understand the impact of these changes in the firm’s earnings before changing their view.3. McDonald's Corp: The fast food chain will report its second quarter results on Monday before the opening bell. According to a Street estimate, the firm is expected to post EPS of $3.08 on revenues of $6.63 billion. Some analysts anticipate its results and guidance will be impacted by the effects of inflation on consumer spending patterns.On the positive side, however, the firm is expected to make a recovery toward the second half of the year following its value meal introduction. Management remains enthusiastic about the potential increase in foot traffic due to this initiative, with 93% of its franchisees opting to extend the promotion through the end of August. Retail agrees with the optimistic take as well, with Stocktwits sentiment in bullish territory (61/100) supported by high message volume.<figure class="image"><a href="https://stocktwits.com/symbol/MCD"><img style="aspect-ratio:1582/458;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_26_at_10_21_01_AM_c7f4b0dfbf.png" alt="Retail sentiment trends in bullish territory for McDonald's Corp" width="1582" height="458"></a><figcaption>Retail sentiment trends in the bullish territory for McDonald's Corp</figcaption></figure>Photo Courtesy: Jurij Kenda on Unsplash

Earnings Preview: Tilray Brands, Beyond Inc. and McDonald’s Report Monday — What Retail Is Thinking

Retail investors are bullish on McDonald’s Corp., but less enthusiastic about Tilray Brands and Beyond Inc.

Retail investors are bullish on McDonald’s Corp., but less enthusiastic about Tilray Brands and Beyond Inc. ahead of earnings.

MJ
Amplify Alternative Harvest ETF

Feed

News

Sentiment

Fundamentals

Info

Latest MJ News

MJAmplify Alternative Harvest ETF